Anaptysbio (ANAB) Interest Coverage Ratio (QoQ) (2016 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 20.85% |
| Sep 30, 2019 | -48.22% |
| Jun 30, 2019 | -22.54% |
| Mar 31, 2019 | -43.70% |
| Dec 31, 2018 | -27.60% |
| Sep 30, 2018 | -27.69% |
| Jun 30, 2018 | 5.37% |
| Mar 31, 2018 | -122.79% |
| Dec 31, 2017 | 22.00% |
| Sep 30, 2017 | -245.43% |
| Jun 30, 2017 | 75.06% |
| Mar 31, 2017 | 18.39% |
| Dec 31, 2016 | -208.56% |
| Sep 30, 2016 | -145.49% |
| Jun 30, 2016 | 305.67% |